Information Provided By:
Fly News Breaks for June 14, 2018
Jun 14, 2018 | 11:40 EDT
H.C. Wainwright analyst Joseph Pantginis attributes recent weakness in shares of Palatin (PTN) to the relaunch of Addyi by Sprout, and its first-to-market status, following reacquisition of the drug from Valeant (VRX). However, he sees the weakness as undeserved, as he continues to believe that Addyi is an inferior drug with a "sketchy history," Pantginis tells investors. Addyi's "one singular advantage," education and visibility for hypoactive sexual desire disorder, should help the market for Palatin's bremelanotide, which has a "potentially market leading profile," said the analyst, who keeps a Buy rating on Palatin shares.
News For PTN;VRX From the Last 2 Days
Jul 14, 2018 | 12:16 EDT
Bill Ackman's Pershing Square Holdings has been battered by a long position in Valeant Pharmaceuticals International (VRX) and a short bet against Herbalife Nutrition (HLF), which have been both closed out, Andrew Bary writes in this week's edition of Barron's. But after a humbling three year stretch, the hedge fund titan could be making a comeback, he adds. Closed-end funds tied to Ackman's and Daniel Loeb's hedge funds offer investors an opportunity to participate in their success, Barron's notes. Reference Link
Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.